Biotech Values

[dewophile]

Basically what you are laying out is a price war

not at all a price war - what i am implying (or at least was trying to ) was just the manner in which SNY is going about trying to maintain some market share. it's obvious they need to come down in price to level of generic. rather than come down across the board and start a price war, they are coming down via contract pricing with certain GPOs/PBMs, but likely leaving others for generic to take - so in fact what i am implying is tacit collusion by giving up sole market to generic while striking exclusives at generic pricing for others
anyway at least that is how i think things will shake out..